| 标题 |
[求助补充材料]
 Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD |
| 网址 | |
| DOI | |
| 其它 |
期刊：Breast Cancer Res Treat 作者：Masuda N, Saji S, Kojima Y, Kitada M, Tada H, Iwasa T, Koizumi K, Iwatani T, Sagara Y, Kuwayama T, Shimoda M, Sasada T, Tsugawa K, Kawaguchi Y, Shimomura A, Yamaguchi T, Hasegawa H, Osaka S, Morita S, Yamashita T 出版日期：2026-07-08 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
v0id
cdercder
大力的冬萱
prigogin
慈祥的又菱
aaaa
arniu2008
明亮尔蓝
XLL小绿绿
嘉心糖
行走的荷尔蒙
ale
丰富语蕊
干净的琦
OK
pluto
完美巧凡
虫培
Mary
皖公网安备34019202002308
